ATE550017T1 - Lasofoxifen-tablette und ihre ummantelung - Google Patents

Lasofoxifen-tablette und ihre ummantelung

Info

Publication number: ATE550017T1
Authority: AT; Austria
Prior art keywords: lasofoxifen; tablet; coating; lasofoxifen tablet
Prior art date: 2002-07-10

Application number

AT03764059T

Other languages

English (en)

Inventor

Daniel S Gierer

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-07-10

Filing date

2003-06-30

Publication date

2012-04-15

2003-06-30 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2012-04-15 Application granted granted Critical

2012-04-15 Publication of ATE550017T1 publication Critical patent/ATE550017T1/de

Links

239000011248 coating agent Substances 0.000 title 1
238000000576 coating method Methods 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds

Landscapes

Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Physical Education & Sports Medicine (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Hematology (AREA)
Obesity (AREA)
Heart & Thoracic Surgery (AREA)
Child & Adolescent Psychology (AREA)
Cardiology (AREA)
Urology & Nephrology (AREA)
Reproductive Health (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

AT03764059T 2002-07-10 2003-06-30 Lasofoxifen-tablette und ihre ummantelung ATE550017T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US39509002P	2002-07-10	2002-07-10
PCT/IB2003/003074 WO2004006895A1 (en)	2002-07-10	2003-06-30	Lasofoxifene tablet and its coating

Publications (1)

Publication Number	Publication Date
ATE550017T1 true ATE550017T1 (de)	2012-04-15

Family

ID=30115812

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT03764059T ATE550017T1 (de)	2002-07-10	2003-06-30	Lasofoxifen-tablette und ihre ummantelung

Country Status (35)

Country	Link
US (2)	US20040057992A1 (de)
EP (1)	EP1534248B1 (de)
JP (2)	JP4446446B2 (de)
KR (1)	KR100782693B1 (de)
CN (1)	CN100344278C (de)
AP (1)	AP2005003201A0 (de)
AR (1)	AR040434A1 (de)
AT (1)	ATE550017T1 (de)
AU (1)	AU2003247017B2 (de)
BR (1)	BR0312563A (de)
CA (1)	CA2489407C (de)
CY (1)	CY1112892T1 (de)
DK (1)	DK1534248T3 (de)
EA (1)	EA007268B1 (de)
EC (1)	ECSP055528A (de)
ES (1)	ES2395123T3 (de)
HN (1)	HN2003000206A (de)
HR (1)	HRP20041196A2 (de)
IL (2)	IL165746A0 (de)
IS (1)	IS7594A (de)
MA (1)	MA27318A1 (de)
MX (1)	MXPA05000394A (de)
NO (1)	NO20050018L (de)
NZ (1)	NZ537278A (de)
OA (1)	OA12883A (de)
PA (1)	PA8576201A1 (de)
PE (1)	PE20040104A1 (de)
PL (1)	PL374913A1 (de)
PT (1)	PT1534248E (de)
SI (1)	SI1534248T1 (de)
TN (1)	TNSN05006A1 (de)
TW (1)	TW200406222A (de)
UY (1)	UY27886A1 (de)
WO (1)	WO2004006895A1 (de)
ZA (1)	ZA200410196B (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PA8576201A1 (es) *	2002-07-10	2004-05-26	Pfizer Prod Inc	Composicion farmaceutica que tiene una distribucion y potencia uniforme de farmaco
US20040253305A1 (en) *	2003-06-12	2004-12-16	Luner Paul E.	Pharmaceutical compositions of atorvastatin
US20050271717A1 (en) *	2003-06-12	2005-12-08	Alfred Berchielli	Pharmaceutical compositions of atorvastatin
WO2006105806A1 (en) *	2005-04-07	2006-10-12	Miso Sabovic	Delaying the ageing process and disorders caused by ageing
CN101198319B (zh) *	2005-04-26	2012-08-01	大日本住友制药株式会社	含有双胍化合物的颗粒制剂
GB0516604D0 (en) *	2005-08-12	2005-09-21	Sandoz Ag	Rapidly dispersing/disintegrating compositions
CA2833706C (en)	2005-11-11	2014-10-21	Boehringer Ingelheim International Gmbh	Quinazoline derivatives for the treatment of cancer diseases
PT3150586T (pt)	2007-02-23	2020-03-31	Gilead Sciences Inc	Moduladores de propriedades farmacocinéticas de agentes terapêuticos
CA2835910C (en) *	2007-04-25	2016-06-28	Warner Chilcott Company, Llc	Improved vitamin d content uniformity in pharmaceutical dosage forms
US20100055180A1 (en) *	2007-10-10	2010-03-04	Mallinckrodt Baker, Inc.	Directly Compressible Granular Microcrystalline Cellulose Based Excipient, Manufacturing Process and Use Thereof
WO2009048557A1 (en) *	2007-10-10	2009-04-16	Mallinckrodt Baker, Inc.	Directly compressible high functionality granular microcrystalline cellulose based excipient, manufacturing process and use thereof
US20090274757A1 (en) *	2008-05-01	2009-11-05	Wyeth	Pharmaceutical polish formulations
EA201591353A1 (ru)	2008-05-02	2016-01-29	Джилид Сайэнс, Инк.	Применение частиц твердого носителя для улучшения технологических характеристик фармацевтического агента
SI2451445T1 (sl) *	2009-07-06	2019-07-31	Boehringer Ingelheim International Gmbh	Postopek za sušenje BIBW2992, njegovih soli in trdnih farmacevtskih formulacij, ki obsegajo to aktivno sestavino
WO2013059146A1 (en) *	2011-10-17	2013-04-25	Lexicon Pharmaceuticals, Inc.	Solid dosage forms of (s)-ethyl 2-amino-3-(4-(2-amino-6-((r)-1-(4-chloro-2-(3-methyl-1h-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethoxy)pyrimidin-4-yl)phenyl)propanoate
JP5818219B2 (ja)	2012-05-14	2015-11-18	塩野義製薬株式会社	６，７−不飽和−７−カルバモイルモルヒナン誘導体含有製剤
EP3043778B1 (de) *	2013-09-13	2017-09-06	Bayer Pharma Aktiengesellschaft	Pharmazeutische zusammensetzungen enthaltendes refametinib
RU2539375C1 (ru) *	2013-11-07	2015-01-20	Общество С Ограниченной Ответственностью "Валента-Интеллект"	Фармацевтическая композиция в форме таблетки и способ ее получения
US9242965B2 (en)	2013-12-31	2016-01-26	Boehringer Ingelheim International Gmbh	Process for the manufacture of (E)-4-N,N-dialkylamino crotonic acid in HX salt form and use thereof for synthesis of EGFR tyrosine kinase inhibitors
CN103830196A (zh) *	2014-03-14	2014-06-04	王志刚	一种酒石酸拉索昔芬分散片及其制备方法
TWI535784B (zh)	2014-08-26	2016-06-01	財團法人工業技術研究院	剪切增稠配方、及包含其之複合材料
CN105434444B (zh) *	2014-09-29	2021-02-05	上海奥奇医药科技有限公司	一种A-失碳-5α雄甾烷化合物的口服制剂
MX382609B (es) *	2016-07-25	2025-03-13	Canopy Growth Corp	Nuevas formulaciones y composiciones de cannabis en comprimidos y métodos para su elaboración.
CN110099680B (zh)	2016-10-11	2021-02-05	杜克大学	Er+乳腺癌的拉索昔芬治疗
CN117771239A (zh)	2018-04-10	2024-03-29	杜克大学	乳腺癌的拉索昔芬治疗
GB202116903D0 (en)	2021-11-18	2022-01-05	Sermonix Pharmaceuticals Inc	Lasofoxifene treatment of aromatase-resistant er+ cancer
CN114288258A (zh) *	2022-02-18	2022-04-08	山东新时代药业有限公司	一种单硝酸异山梨酯片及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4182A (en) *		1845-09-09		Island
US4880636A (en) *	1988-05-13	1989-11-14	Franz Robert M	Film coated tablet of ranitidine HCl
US5552412A (en) *	1995-01-09	1996-09-03	Pfizer Inc	5-substitued-6-cyclic-5,6,7,8-tetrahydronaphthalen2-ol compounds which are useful for treating osteoporosis
UA51676C2 (uk) *	1995-11-02	2002-12-16	Пфайзер Інк.	(-)цис-6(s)-феніл-5(r)[4-(2-піролідин-1-ілетокси)феніл]-5,6,7,8-тетрагідронафталін-2-ол d-тартрат, спосіб його одержання, спосіб лікування захворювань, що піддаються лікуванню агоністами естрогену, та фармацевтична композиція
TW442286B (en) *	1996-02-28	2001-06-23	Pfizer	New therapeutic uses of estrogen agonists
US6372457B1 (en)	1997-01-14	2002-04-16	Arkion Life Sciences Llc	Process and materials for production of glucosamine
KR200161927Y1 (ko) *	1997-08-26	1999-12-01	윤종용	냉장고
YU26700A (sh) *	1999-05-24	2002-06-19	Pfizer Products Inc.	Postupak za cis-1-(2-(4-(6-metoksi-2-fenil-1,2,3,4- tetrahidronaftalen-1-il)fenoksi)etil)pirolidin
US6436977B1 (en) *	1999-09-29	2002-08-20	Pfizer Inc.	Dosing regimens for lasofoxifene
US6419956B1 (en) *	1999-12-30	2002-07-16	Ancile Pharmaceuticals	Odor-masking coating for a pharmaceutical preparation
EP1145719A3 (de) *	2000-03-10	2001-11-14	Pfizer Products Inc.	Verwendung von einem Ferrosalz zur Hemmung des oxidativen Abbaus von pharmazeutischen Zusammensetzungen
AR029538A1 (es) *	2000-07-06	2003-07-02	Wyeth Corp	Composiciones farmaceuticas de agentes estrogenicos
AP2003002900A0 (en) *	2001-05-01	2003-12-31	Pfizer Prod Inc	Method for manufacturing a low dose pharmaceutical composition
PA8576201A1 (es) *	2002-07-10	2004-05-26	Pfizer Prod Inc	Composicion farmaceutica que tiene una distribucion y potencia uniforme de farmaco

2003
- 2003-06-23 PA PA20038576201A patent/PA8576201A1/es unknown
- 2003-06-30 ES ES03764059T patent/ES2395123T3/es not_active Expired - Lifetime
- 2003-06-30 DK DK03764059.6T patent/DK1534248T3/da active
- 2003-06-30 WO PCT/IB2003/003074 patent/WO2004006895A1/en not_active Ceased
- 2003-06-30 HR HR20041196A patent/HRP20041196A2/hr not_active Application Discontinuation
- 2003-06-30 CN CNB038162881A patent/CN100344278C/zh not_active Expired - Fee Related
- 2003-06-30 IL IL16574603A patent/IL165746A0/xx unknown
- 2003-06-30 EA EA200401583A patent/EA007268B1/ru not_active IP Right Cessation
- 2003-06-30 PL PL03374913A patent/PL374913A1/xx not_active Application Discontinuation
- 2003-06-30 JP JP2004521001A patent/JP4446446B2/ja not_active Expired - Fee Related
- 2003-06-30 AU AU2003247017A patent/AU2003247017B2/en not_active Ceased
- 2003-06-30 AP AP2005003201A patent/AP2005003201A0/xx unknown
- 2003-06-30 PT PT03764059T patent/PT1534248E/pt unknown
- 2003-06-30 BR BR0312563-7A patent/BR0312563A/pt not_active IP Right Cessation
- 2003-06-30 NZ NZ537278A patent/NZ537278A/en unknown
- 2003-06-30 OA OA1200500007A patent/OA12883A/en unknown
- 2003-06-30 MX MXPA05000394A patent/MXPA05000394A/es active IP Right Grant
- 2003-06-30 EP EP03764059A patent/EP1534248B1/de not_active Expired - Lifetime
- 2003-06-30 SI SI200332150T patent/SI1534248T1/sl unknown
- 2003-06-30 KR KR1020057000369A patent/KR100782693B1/ko not_active Expired - Fee Related
- 2003-06-30 AT AT03764059T patent/ATE550017T1/de active
- 2003-06-30 CA CA002489407A patent/CA2489407C/en not_active Expired - Fee Related
- 2003-07-01 US US10/612,679 patent/US20040057992A1/en not_active Abandoned
- 2003-07-04 TW TW092118389A patent/TW200406222A/zh unknown
- 2003-07-07 HN HN2003000206A patent/HN2003000206A/es unknown
- 2003-07-07 PE PE2003000682A patent/PE20040104A1/es not_active Application Discontinuation
- 2003-07-08 AR AR20030102454A patent/AR040434A1/es not_active Application Discontinuation
- 2003-07-08 UY UY27886A patent/UY27886A1/es not_active Application Discontinuation
2004
- 2004-12-13 IL IL165746A patent/IL165746A/en active IP Right Grant
- 2004-12-13 IS IS7594A patent/IS7594A/is unknown
- 2004-12-17 ZA ZA200410196A patent/ZA200410196B/en unknown
2005
- 2005-01-03 NO NO20050018A patent/NO20050018L/no not_active Application Discontinuation
- 2005-01-10 TN TNP2005000006A patent/TNSN05006A1/fr unknown
- 2005-01-10 MA MA28036A patent/MA27318A1/fr unknown
- 2005-01-10 EC EC2005005528A patent/ECSP055528A/es unknown
2006
- 2006-11-09 JP JP2006303440A patent/JP2007031451A/ja active Pending
- 2006-12-22 US US11/615,511 patent/US7553500B2/en not_active Expired - Fee Related
2012
- 2012-06-06 CY CY20121100504T patent/CY1112892T1/el unknown

Also Published As

Publication number	Publication date
OA12883A (en)	2006-09-15
CA2489407C (en)	2009-01-27
EA200401583A1 (ru)	2005-06-30
US7553500B2 (en)	2009-06-30
CN1668285A (zh)	2005-09-14
TNSN05006A1 (fr)	2007-05-14
AR040434A1 (es)	2005-04-06
NZ537278A (en)	2007-07-27
JP2005535671A (ja)	2005-11-24
ZA200410196B (en)	2006-07-26
MXPA05000394A (es)	2005-03-23
UY27886A1 (es)	2004-02-27
CA2489407A1 (en)	2004-01-22
EP1534248A1 (de)	2005-06-01
PL374913A1 (en)	2005-11-14
AU2003247017A1 (en)	2004-02-02
IS7594A (is)	2004-12-13
TW200406222A (en)	2004-05-01
KR20050017102A (ko)	2005-02-21
US20040057992A1 (en)	2004-03-25
IL165746A0 (en)	2006-01-15
PT1534248E (pt)	2012-05-25
PE20040104A1 (es)	2004-02-27
EP1534248B1 (de)	2012-03-21
EA007268B1 (ru)	2006-08-25
HN2003000206A (es)	2004-07-27
NO20050018L (no)	2005-01-12
BR0312563A (pt)	2005-04-19
CY1112892T1 (el)	2016-04-13
ECSP055528A (es)	2005-03-10
MA27318A1 (fr)	2005-05-02
AP2005003201A0 (en)	2005-03-31
SI1534248T1 (sl)	2012-07-31
ES2395123T3 (es)	2013-02-08
AU2003247017B2 (en)	2008-03-06
CN100344278C (zh)	2007-10-24
JP2007031451A (ja)	2007-02-08
DK1534248T3 (da)	2012-06-25
IL165746A (en)	2008-12-29
HRP20041196A2 (en)	2005-04-30
WO2004006895A1 (en)	2004-01-22
KR100782693B1 (ko)	2007-12-07
PA8576201A1 (es)	2004-05-26
JP4446446B2 (ja)	2010-04-07
US20070110800A1 (en)	2007-05-17
HK1077747A1 (en)	2006-02-24

Publication	Publication Date	Title
IS7594A (is)	2004-12-13	Laxófoxifen tafla og húðun hennar
DE60326611D1 (de)	2009-04-23	N und dergleichen
ATE380544T1 (de)	2007-12-15	Umhüllte feste darreichungsform
EP1514544A4 (de)	2009-01-07	Antiallergikum
DK1474420T3 (da)	2012-05-21	Quinazolinforbindelser
DE60328735D1 (de)	2009-09-17	Chinazolinderivate
EP1549332A4 (de)	2008-06-18	Modifizierte asialo-interferone und ihre verwendungen
ATE370931T1 (de)	2007-09-15	Heterozyklische verbindungen und ihre verwendungen
EP1485754A4 (de)	2008-08-13	Warenanzeigetasche und system
IS7749A (is)	2005-03-17	Pýrimídínafleiður og notkun þeirra sem CB2 beina
DE60328206D1 (de)	2009-08-13	Scheibenwaschanlagendüse und scheibenwaschanlage
DE60315872D1 (de)	2007-10-04	Pulverlack
DE602004028934D1 (de)	2010-10-14	Benzoä4,5üthienoä2,3-düpyrimidin-4-one und ihre therapeutische verwendung
DE60330269D1 (de)	2010-01-07	Piperazinyl- und diazapanylbenzamide und-benzothioamide
DE60230608D1 (de)	2009-02-12	Tyra-gene und ihre verwendung
DE50310453D1 (de)	2008-10-16	Flächiges Metallelement und Profilelement
DE60316300D1 (de)	2007-10-25	Maiswurzel-spezifische promotoren und ihre verwendungen
DE60318317D1 (de)	2008-02-07	Acylaminothiazolderivate und ihre vewrendung als beta-amyloid inhibitoren
DE60209673D1 (de)	2006-05-04	Tablettenbeschichtungen
DE60221576D1 (de)	2007-09-13	Lötlegierung und lötverbindung
DE50305140D1 (de)	2006-11-02	Zerstäubungsanordnung
EP1583528A4 (de)	2009-10-21	Nf-kb inhibitoren und ihre verwendungen
DE60223586D1 (de)	2007-12-27	Frühstückszerealien
DE50313548D1 (de)	2011-04-28	Zerstäubungsanordnung
BRPI0311588A2 (pt)	2016-06-28	revestimento